Asthma in Children — Role of Technology in Improving Asthma Management In School Staff
Citation(s)
Fitzgerald DA, Gillis J Asthma deaths in children in New South Wales 2004-2013: Could we have done more? J Paediatr Child Health. 2015 Nov;51(11):1127-33. doi: 10.1111/jpc.12947. Epub 2015 Jul 1.
Henry RL, Hazell J, Halliday JA Two hour seminar improves knowledge about childhood asthma in school staff. J Paediatr Child Health. 1994 Oct;30(5):403-5.
Kawafha MM, Tawalbeh LI The effect of asthma education program on knowledge of school teachers: a randomized controlled trial. West J Nurs Res. 2015 Apr;37(4):425-40. doi: 10.1177/0193945914528070. Epub 2014 Mar 29.
Shah S, Gibson PG, Wachinger S Recognition and crisis management of asthma in schools. J Paediatr Child Health. 1994 Aug;30(4):312-5.
Soo YY, Saini B, Moles RJ Can asthma education improve the treatment of acute asthma exacerbation in young children? J Paediatr Child Health. 2013 May;49(5):353-60. doi: 10.1111/j.1440-1754.2012.02551.x. Epub 2012 Sep 12. Review.
Wesseldine LJ, McCarthy P, Silverman M Structured discharge procedure for children admitted to hospital with acute asthma: a randomised controlled trial of nursing practice. Arch Dis Child. 1999 Feb;80(2):110-4.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
